Earnings History Data for Addex Therapeutics Ltd (ADXN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical-stage pharmaceutical company. It is focused on the development and commercialization of small molecule drugs for neurological disorders. The company's lead drug candidate includes dipraglurant, ADX71149 which are in clinical stage. Its Preclinical programs include GABAB PAM for CMT1A, mGlu7 NAM for PTSD, mGlu2 NAM for mild neurocognitive disorders, mGlu4 PAM for Parkinson's disease and mGlu3 PAM for neurodegenerative disorders. GABAB PAM program has been licensed to Indivior PLC for the treatment of addiction. Addex Therapeutics Ltd is based in Geneva, Switzerland.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
05-08-2021 PM 1:00 AM ET
(Aug 5)
ADXN Addex Therapeutics Ltd 71.35 -0.77 -0.65 -0.75 Addex Therapeutics reports Q2 results
[8/5/2021 1:58 AM]
9.85 0.01 
(0.05%)
0.0 0.0 
(0.00%)
8.88 - 37.52 1,214 0 0
05-05-2021 PM 1:00 AM ET
(May 5)
ADXN Addex Therapeutics Ltd 71.03 -0.53 -0.65 -0.99 Addex Therapeutics reports Q1 results
[5/5/2021 2:06 AM]
9.81 0.07 
(0.72%)
0.0 0.0 
(0.00%)
7.00 - 37.52 1,556 10,000 0